Abstract: Embodiments are directed towards methods for purifying a reclaimed polymer.

Abstract: A wireless access device can be configured to determine a list of accessory groups corresponding to accessories connected to a network managed by the wireless access device. The wireless access device may also be configured to identify at least one firmware update that corresponds to at least one accessory group of the list of accessory groups and request all firmware updates that correspond to the at least one accessory group. The wireless access device can also be configured to receive one or more firmware updates that corresponds to at least one of the accessories of the at least one accessory group for which a respective firmware update is available and transmit at least one firmware update of the received one or more firmware updates to at least one corresponding accessory of the at least one accessory group.

Abstract: Provided herein are compositions and methods for the cryopreservation of immune cells, such as peripheral blood mononuclear cells (PBMCs) by pre-treating the cells with a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein) prior to freezing. Kits for practicing the methods are also provided herein.

Abstract: An equipment panel includes one or more trays disposed within a chassis. Each tray has a two-layer termination region. Certain trays have a two-layer splice region. The splice region can be used to optically couple preterminated fibers within the tray to a trunk cable. Alternatively or in addition, the splice region can be used to fix broken fiber connections. A cable anchor and fanout arrangement mounts to the chassis as a unit.

Abstract: Novel wax compositions are provided herein comprising at least about 85 wt. % of linear alpha olefins having a carbon number of at least 18, about 8 wt. % to about 40 wt. % of linear alpha olefins having a carbon number of 20, and about 5 wt. % to about 30 wt. % of linear alpha olefins having a carbon number of at least 30. The present wax compositions yield smooth, one-pour container candle waxes and provide ideal container candle burn performance demonstrated by low sooting behavior and a balanced wax consumption.

Abstract: A cabin attendant seat is disclosed. The seat may include a seat pan and a seatback. The seat may include a device holder coupled to the seat pan. The device holder may include a main body including a plurality of main body walls that define a main body cavity and a cover including a plurality of cover walls that define a cover cavity. The main body cavity and the cover cavity may form a device holder cavity configured to stow a mobile device. The device holder may include an opening configured to receive the mobile device. The device holder may include a device securing assembly configured to rotate between a first and second position, when in the first position the securing assembly configured to secure the mobile device within the cavity, when in the second position the mobile device configured to be removed from the device holder cavity.

Abstract: An automated system for allocation of resources in a cluster configured to run a search engine is disclosed. At least one master node includes a processing system. The processing system is configured to analyze the cluster based on measurements of different parameters. The results of the analysis can be used to allocate or reallocate the shards, allocate or reconfigure the workload portions assigned to the shards, and allocate or reconfigure the shards selectively to maintain high performance. Periodic analyses can predict future behavior, and reconciliations toward a target allocation can occur regularly to maximize system efficiency and performance.

Abstract: Compositions and methods are provided for treating myopathies by administering a complex formed between a therapeutic mRNA polynucleotide and a 3E10 antibody or variant thereof, or antigen-binding fragment thereof. In some instances, the complexes are stabilized through a molar ratio of 3E10 antibody or variant thereof, or antigen-binding fragment thereof to therapeutic polynucleotide of at least about 2:1.

Abstract: Compositions and methods are provided for delivering therapeutic polynucleotides by administering a complex formed between a therapeutic polynucleotide having a 3E10 or 3E10 variant binding domain and a 3E10 antibody or variant thereof, or antigen-binding fragment thereof. In some instances, the complexes are stabilized through a molar ratio of 3E10 antibody or variant thereof, or antigen-binding fragment thereof to therapeutic polynucleotide of at least about 2:1.

Abstract: A cabin attendant seat is disclosed. The seat may include a seat pan and a seatback. The seat may include a device holder coupled to the seat pan. The device holder may include a main body including a plurality of main body walls that define a main body cavity and a cover including a plurality of cover walls that define a cover cavity. The main body cavity and the cover cavity may form a device holder cavity configured to stow a mobile device. The device holder may include an opening configured to receive the mobile device. The device holder may include a device securing assembly configured to rotate between a first and second position, when in the first position the securing assembly configured to secure the mobile device within the cavity, when in the second position the mobile device configured to be removed from the device holder cavity.

Abstract: Novel wax compositions are provided herein comprising at least about 85 wt. % of linear alpha olefins having a carbon number of at least 18, about 8 wt. % to about 40 wt. % of linear alpha olefins having a carbon number of 20, and about 5 wt. % to about 30 wt. % of linear alpha olefins having a carbon number of at least 30. The present wax compositions yield smooth, one-pour container candle waxes and provide ideal container candle burn performance demonstrated by low sooting behavior and a balanced wax consumption.

Abstract: Embodiments of the present invention provide a centralized for allowing communication and transmission of data between entities and third party entities to securely provide requisitions to users. The system is configured for receiving a requisition request from an entity system, wherein the requisition request is associated with a user, in response to receiving the requisition request, performing one or more data transformations to transform at least a part of data associated with the requisition request, transmitting transformed data associated with the requisition request to an intermediary system, transmitting one or more control signals to the intermediary system to cause the intermediary system to transmit the transformed data associated with the requisition request to one or more third party entities, and determining that the intermediary system received one or more requisitions from the one or more third party entities.

Abstract: Compositions and methods of use thereof for delivering nucleic acid cargo into cells are provided. The compositions typically include (a) a 3E10 monoclonal antibody or an antigen binding, cell-penetrating fragment thereof; a monovalent, divalent, or multivalent single chain variable fragment (scFv); or a diabody; or humanized form or variant thereof, and (b) a nucleic acid cargo including, for example, a nucleic acid encoding a polypeptide, a functional nucleic acid, a nucleic acid encoding a functional nucleic acid, or a combination thereof. Elements (a) and (b) are typically non-covalently linked to form a complex.

Abstract: Provided herein are deposition systems utilizing coated grids in an ion deposition process which provide more predictable erosion of the coating rather than erosion of the grid itself. Further, coatings may be utilized in which the coating material does not act as a contaminant to the deposition process, thereby eliminating contamination of the sample surface due to deposition of unwanted grid material. Also provided are methods of refurbishing a coated grid by periodically replacing the coating material thus protecting the grid itself and allowing a grid to be used indefinitely.

Abstract: A system is provided for facilitating access to data stored in a cloud-based storage service. Data associated with a user account is stored at the cloud-based storage service. A portion of the data is associated with a heightened authentication protocol. A request for an application to receive data that is associated with the heightened authentication protocol is received at the cloud-based storage service. In response to the request, the request is authenticated based on the heightened authentication protocol. In response to authenticating the request, permission is granted for the application to receive the data that is associated with the heightened authentication protocol. In response to a locking of the data that is associated with the heightened authentication protocol, an indication that the data is unavailable is sent to the application.

Abstract: Provided herein are compositions and methods for treating T cell exhaustion in a subject, by administering a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein) or immune cells treated with a PTD-MYC fusion protein. Kits for use in practicing the methods are also provided herein.

Abstract: A system is provided for controlling access to data stored in a cloud-based storage service. A first request is received to access data stored at the cloud-based storage service, the data associated with a user account. The first request is authenticated based on a username and password associated with the user account. A second request is received for a file that is stored in an area associated with a heightened authentication protocol. The heightened authentication protocol is performed to authenticate the second request. In response to authenticating the second request, permission is granted to a temporary strong authentication state. The permission is to access the file that is stored in the area associated with the heightened authentication protocol.

Abstract: A system is provided for controlling access to data stored in a cloud-based storage service. A first request is received to access data stored at the cloud-based storage service, the data associated with a user account. The first request is authenticated based on a username and password associated with the user account. A second request is received for a file that is stored in an area associated with a heightened authentication protocol. The heightened authentication protocol is performed to authenticate the second request. In response to authenticating the second request, permission is granted to a temporary strong authentication state. The permission is to access the file that is stored in the area associated with the heightened authentication protocol.

Abstract: Provided herein are compositions and methods for the cryopreservation of immune cells, such as peripheral blood mononuclear cells (PBMCs) by pre-treating the cells with a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein) prior to freezing. Kits for practicing the methods are also provided herein.

Abstract: Disclosed herein are phytomedicine analytics for research optimization at scale (PhAROS) methods for discovering and/or optimizing polypharmaceutical medicines, the PhAROS method comprising: analyzing, in a single computational space, data from a plurality of traditional medicine systems (TMS), wherein the analysis uses transcultural dictionaries to allow searches within distinct TMS data sets embodying different epistemologies and terminologies, Wherein the analysis uses data returned by a query to identify new polypharmaceutical and/or optimized polypharmaceutical compositions.